Kexing Biopharm Co., Ltd. (SHA:688136)
China · Delayed Price · Currency is CNY 20.78
-0.39 (-1.84%)
Sep 2, 2026, 3:00 PM CST
Kexing Biopharm Market Cap
Kexing Biopharm has a market cap or net worth of 4.19 billion as of September 1, 2026. Its market cap has decreased by -53.40% in one year.
Market Cap
4.19B
Enterprise Value
5.04B
Revenue
1.44B
Ranking
n/a
PE Ratio
20.01
Stock Price
20.78
ChartMarket Cap Chart
Since December 14, 2020, Kexing Biopharm's market cap has decreased from 8.15B to 4.19B, a decrease of -48.60%. That is a compound annual growth rate of -10.98%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2026 | 4.19B | -33.24% |
| Dec 31, 2025 | 6.27B | 45.13% |
| Dec 31, 2024 | 4.32B | 7.17% |
| Dec 29, 2023 | 4.03B | -5.31% |
| Dec 30, 2022 | 4.26B | -24.16% |
| Dec 31, 2021 | 5.62B | -30.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 14, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding